Key result
Genome regulation differences among Asian ethnic groups linked to diabetes and chronic disease risks.
Why the study?
Asian populations are under-represented in population-based, clinical, and genomic research.
The HELIOS study establishes a comprehensive multi-omics precision medicine cohort for Asian populations, revealing significant ethnic-specific differences in genomic regulation, metabolism, and chronic disease risk.
Highlights need for Asian-inclusive precision medicine; leaves open clinical translation pending prospective validation.
Asian people are under-represented in population-based, clinical, and genomic research. To address this gap, we have initiated the Health for Life in Singapore (HELIOS) longitudinal cohort study, comprising comprehensive behavioural, phenotypic, and genomic measurements from 10,004 Asian men and women of Chinese, Indian or Malay background. Phenotyping has been carried out using validated approaches, that are internationally interoperable. Health record linkage enriches both baseline phenotyping and evaluation of prospective outcomes. The integrated multi-omics data include whole-genome and RNA sequencing, quantification of DNA methylation, and metabolomic profiling. Our data reveal extensive lifestyle, physiological, genomic, and molecular diversity between the distinct Asian ethnic groups, and the biological interconnectivity between functional layers. This includes characterisation of divergent patterns of genome regulation between Asian individuals, that correlate with differences in educational attainment, dietary quality, and adiposity, and which overlap transcription factors and DNA methylation sites linked to the development of diabetes and other chronic diseases. Our unique HELIOS Asian Precision Medicine cohort study represents a state-of-the-art platform to enable biomedical researchers to understand the aetiology and pathogenesis of diverse disease outcomes in Asia, and to generate insights that have the potential to improve health outcomes for Asian populations globally.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question. The HELIOS study reveals genome regulation differences among Asian ethnic groups linked to diabetes and chronic disease risks, supported by data from 10,004 participants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: